Early intervention improves mortality and hospitalization rates in incident hemodialysis patients: RightStart program

被引:63
作者
Wingard, Rebecca L.
Pupim, Lara B.
Krishnan, Mahesh
Shintani, Ayumi
Ikizler, T. Alp
Hakim, Raymond M.
机构
[1] Vanderbilt Univ, Med Ctr, Div Nephrol, Nashville, TN 37232 USA
[2] Fresenius Med Care N Amer Inc, Nashville, TN USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 2卷 / 06期
关键词
D O I
10.2215/CJN.04261206
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Annualized mortality rates of chronic hemodialysis (CHD) patients in their first 90 d of treatment range from 24 to 50%. Limited studies also show high hospitalization rates. It was hypothesized that a structured quality improvement program (RightStart), focused on medical needs and patient education and support, would improve outcomes for incident CHD patients. Design, setting, participants, & measurements: A total of 918 CHD incident patients were prospectively enrolled in a multicenter RightStart Program, and compared with a time-concurrent group of 1020 control patients from non-RightStart clinics. RightStart patients received 3 mo of intervention in management of anemia, dosage of dialysis, nutrition, and dialysis access and a comprehensive educational program. Outcomes were tracked for up to 12 mo. Results: At 3 mo, RightStart patients had higher albumin and hematocrit values. Dose of dialysis and permanent access placement were not statistically significantly different from control subjects. Compared with baseline, Mental Composite Score for RightStart patients improved significantly. Mean hospitalization days per patient year were reduced with RightStart versus control subjects. Mortality rates at 3, 6, and 12 mo were 20, 18, and 17 for RightStart patients versus 39, 33, and 30 deaths per 100 patient-years for control subjects, respectively. Conclusions: A structured program of prompt medical and educational strategies in incident CHD patients results in improved morbidity and mortality that last up to 1 yr.
引用
收藏
页码:1170 / 1175
页数:6
相关论文
共 24 条
[1]   Overcoming barriers that inhibit proper treatment of anemia [J].
Agarwal, R .
KIDNEY INTERNATIONAL, 2006, 69 :S9-S12
[2]  
[Anonymous], 2001, Am J Kidney Dis, V37, pS182
[3]  
[Anonymous], US REN DAT SYST USRD
[4]  
*CTR MED MED SERV, 2004, ANN REP END STAG REN, P30
[5]   Type of vascular access and mortality in US hemodialysis patients [J].
Dhingra, RK ;
Young, EW ;
Hulbert-Shearon, TE ;
Leavey, SF ;
Port, FK .
KIDNEY INTERNATIONAL, 2001, 60 (04) :1443-1451
[6]   Effect of dialysis dose and membrane flux in maintenance hemodialysis. [J].
Eknoyan, G ;
Beck, GJ ;
Cheung, AK ;
Daugirdas, JT ;
Greene, T ;
Kusek, JW ;
Allon, M ;
Bailey, J ;
Delmez, JA ;
Depner, TA ;
Dwyer, JT ;
Levey, AS ;
Levin, NW ;
Milford, E ;
Ornt, DB ;
Rocco, MV ;
Schulman, G ;
Schwab, SJ ;
Teehan, BP ;
Toto, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2010-2019
[7]   Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The dialysis outcomes and practice patterns study (DOPPS) [J].
Goodkin, DA ;
Bragg-Gresham, JL ;
Koenig, KG ;
Wolfe, RA ;
Akiba, T ;
Andreucci, VE ;
Saito, A ;
Rayner, HC ;
Kurokawa, K ;
Port, FK ;
Held, PJ ;
Young, EW .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (12) :3270-3277
[8]   DEVELOPMENT OF THE KIDNEY-DISEASE QUALITY-OF-LIFE (KDQOL(TM)) INSTRUMENT [J].
HAYS, RD ;
KALLICH, JD ;
MAPES, DL ;
COONS, SJ ;
CARTER, WB .
QUALITY OF LIFE RESEARCH, 1994, 3 (05) :329-338
[9]   Nutrition in end-stage renal disease [J].
Ikizler, TA ;
Hakim, RM .
KIDNEY INTERNATIONAL, 1996, 50 (02) :343-357
[10]  
IKIZLER TA, 1995, J AM SOC NEPHROL, V6, P1386